Overview
Lobbying Costs
450,000€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
1.25 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
7
Lobbying Costs over the years
-
Info
AstraZeneca PLC
EU Transparency Register
249402638316-62 First registered on 28 May 2020
Goals / Remit
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Main EU files targeted
Our engagement with the EU institutions focuses, among others, on the following topics:
- Healthcare
- Pharmaceutical policy
- R&D
- Trade
- Sustainability
- Environment
- Public Health
- Industrial Policy
- Intellectual PropertyAddress
Head Office
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
UNITED KINGDOMEU Office
Alfons Gossetlaan 40
Groot-Bijgaarden 1702
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 100% 1 25% 1 Lobbyists (Full time equivalent)
1.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 28 May 2021
Name Start date End Date Ava LLOYD 20 Mar 2024 02 Oct 2024 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
European Federation of Pharmaceutical Industries and Associations (EFPIA) - www.efpia.eu
European Roundtable For Industry (ERT) - www.ert.eu
International Pharmaceutical Aerosol Consortium (IPAC) - www.ipacinhaler.org
European Alliance for Personalised Medicine (EAPM) - www.EUAPM.euMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
450,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
7 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 12 Apr 2021 Location Brussels Subject Vaccine production and delivery schedule for Q2 2021 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 11 Apr 2021 Location Videocall Subject Vaccine production and deliveries Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
-
Date 11 Feb 2021 Location webex Subject vaccines - delivery schedule DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 01 Feb 2021 Location webex Subject vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 21 Jan 2021 Location webex Subject follow up vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 11 Jan 2021 Location Skype Subject Follow-up over vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)